Spots Global Cancer Trial Database for Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer
Official Title: Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer
Study ID: NCT00199537
Interventions
Study Description
Brief Summary: Patients with advanced prostate cancer undergoing adjuvant treatment with androgen blockade will be followed over a 1 year interval to assess the effects of this treatment on bone metabolism. It is expected that men undergoing androgen blockade will experience accelerated bone loss.
Detailed Description:
Keywords
Eligibility
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Urology Clinic & Prostate Centre, St. Joseph's Hospital, St. Joseph's Health Care London, London, Ontario, Canada
Contact Details
Name: Hassan Razvi, MD, FRCSC
Affiliation: Urology, St. Joseph's Hospital, University of Western Ontario
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
